Arnon Aharon
Chief Tech/Sci/R&D Officer en CLAL BIOTECHNOLOGY INDUSTRIES LTD. .
Perfil
Arnon Aharon founded ProMining Therapeutics Ltd.
Presently, Dr. Aharon is Medical Director for Clal Biotechnology Industries Ltd.
He previously held the position of Chief Medical Officer of BioLineRx Ltd., Chief Clinical Research Officer at PainReform Ltd., Chief Medical Officer for Chemomab Therapeutics Ltd., Partner at R&d Integrative Solutions, Medical Director of LycoRed Ltd., Medical Director at Thrombotech Ltd.
and Vice President-Development at Pharmos Ltd.
Arnon Aharon received a doctorate and an undergraduate degree from Tel-Aviv University.
Cargos activos de Arnon Aharon
Empresas | Cargo | Inicio |
---|---|---|
CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Antiguos cargos conocidos de Arnon Aharon.
Empresas | Cargo | Fin |
---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 03/12/2021 |
LycoRed Ltd.
LycoRed Ltd. Pharmaceuticals: MajorHealth Technology Lycored Ltd. provides functional and nutritional ingredient solutions. It supplies natural carotenoids and other nutritional ingredients. The company was founded in 1985 and is headquartered in Beer Sheva, Israel. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Chief Tech/Sci/R&D Officer | 01/01/2012 |
ProMining Therapeutics Ltd.
ProMining Therapeutics Ltd. BiotechnologyHealth Technology ProMining Therapeutics Ltd. provides biopharmaceutical research and development services. It is an early-stage biopharmaceutical research and development company engaged in the discovery and development of novel oral, small-molecule drugs for treatment of cancer, inflammation, chronic pain, and cardiovascular and viral diseases. The company was founded in 2011 and is headquartered in Nes Ziona, Israel. | Founder | - |
BIOLINERX LTD. | Chief Tech/Sci/R&D Officer | - |
Formación de Arnon Aharon.
Tel-Aviv University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
BIOLINERX LTD. | Health Technology |
PAINREFORM LTD. | Health Technology |
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Empresas privadas | 6 |
---|---|
LycoRed Ltd.
LycoRed Ltd. Pharmaceuticals: MajorHealth Technology Lycored Ltd. provides functional and nutritional ingredient solutions. It supplies natural carotenoids and other nutritional ingredients. The company was founded in 1985 and is headquartered in Beer Sheva, Israel. | Health Technology |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Health Technology |
Pharmos Ltd. | |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
R&d Integrative Solutions | |
ProMining Therapeutics Ltd.
ProMining Therapeutics Ltd. BiotechnologyHealth Technology ProMining Therapeutics Ltd. provides biopharmaceutical research and development services. It is an early-stage biopharmaceutical research and development company engaged in the discovery and development of novel oral, small-molecule drugs for treatment of cancer, inflammation, chronic pain, and cardiovascular and viral diseases. The company was founded in 2011 and is headquartered in Nes Ziona, Israel. | Health Technology |